Xarelto
- Product NDC
- 71610-690
- 11-digit product format
- 716100690
- Labeler code
- 71610
- Product ID
- 71610-690_d0758929-1cc8-4ac2-807e-969a8c7f6c77
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rivaroxaban
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA022406
- Marketing category
- NDA
- Marketing start
- 2011-07-01
- Substance
- RIVAROXABAN
- Active strength
- 10 mg/1
- Pharmacologic classes
- Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Xarelto
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIVAROXABAN | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9NDF7JZ4M3 |
| Rxcui | 1114198, 1114202 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-690-42 | Xarelto | 1800 in 1 BOTTLE | TABLET, FILM COATED | 1800 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-690 | XARELTO (RIVAROXABAN) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Current NDC, 1 package rows | 20230221_38b11f5d-f0fc-46dc-aef1-ea31872bb621.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-690-42 | 71610069042 | 1800 TABLET, FILM COATED in 1 BOTTLE (71610-690-42) | 2023-02-17 | No | No | Current |